Dow Chemical Co. (NYSE:DOW) was downgraded by analysts at Vetr from a “buy” rating to a “hold” rating in a research report issued on Wednesday. They currently have a $57.93 price objective on the stock. Vetr‘s target price indicates a potential upside of 3.97% from the stock’s previous close.

A number of other equities research analysts have also recently weighed in on the stock. Zacks Investment Research raised shares of Dow Chemical from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a research report on Wednesday, October 5th. Citigroup Inc. raised shares of Dow Chemical from a “neutral” rating to a “buy” rating and upped their target price for the company from $55.00 to $59.00 in a report on Monday, October 3rd. RBC Capital Markets set a $65.00 target price on shares of Dow Chemical and gave the company a “buy” rating in a report on Tuesday, September 20th. Finally, Royal Bank Of Canada upped their target price on shares of Dow Chemical from $65.00 to $68.00 and gave the company a “top pick” rating in a report on Friday, October 28th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. Dow Chemical currently has an average rating of “Buy” and a consensus target price of $61.21.

Analyst Recommendations for Dow Chemical (NYSE:DOW)

Dow Chemical (NYSE:DOW) traded up 3.20% during midday trading on Wednesday, hitting $55.72. The stock had a trading volume of 18,316,997 shares. The stock has a market cap of $62.48 billion, a price-to-earnings ratio of 8.68 and a beta of 1.20. Dow Chemical has a 12 month low of $40.26 and a 12 month high of $57.10. The stock has a 50 day moving average of $53.77 and a 200 day moving average of $52.81.

Dow Chemical (NYSE:DOW) last announced its quarterly earnings results on Thursday, October 27th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.12. Dow Chemical had a net margin of 16.91% and a return on equity of 17.81%. The firm earned $12.48 billion during the quarter, compared to analysts’ expectations of $12.01 billion. During the same period in the previous year, the company earned $0.82 earnings per share. Dow Chemical’s quarterly revenue was up 3.7% compared to the same quarter last year. Analysts expect that Dow Chemical will post $3.65 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was first posted by Financial Market News and is owned by of Financial Market News. If you are accessing this article on another website, it was copied illegally and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be read at http://www.financial-market-news.com/vetr-inc-lowers-dow-chemical-co-dow-to-hold/1211507/.

Several hedge funds have recently added to or reduced their stakes in DOW. Abner Herrman & Brock LLC raised its stake in Dow Chemical by 38.1% in the third quarter. Abner Herrman & Brock LLC now owns 37,357 shares of the company’s stock valued at $1,936,000 after buying an additional 10,305 shares in the last quarter. Huntington National Bank raised its stake in Dow Chemical by 70.7% in the second quarter. Huntington National Bank now owns 496,787 shares of the company’s stock valued at $24,695,000 after buying an additional 205,820 shares in the last quarter. Capstone Asset Management Co. raised its stake in Dow Chemical by 262.2% in the third quarter. Capstone Asset Management Co. now owns 303,877 shares of the company’s stock valued at $15,750,000 after buying an additional 219,973 shares in the last quarter. PGGM Investments raised its stake in Dow Chemical by 2.5% in the second quarter. PGGM Investments now owns 784,601 shares of the company’s stock valued at $39,003,000 after buying an additional 18,878 shares in the last quarter. Finally, Bristol Gate Capital Partners Inc. raised its stake in Dow Chemical by 3.0% in the third quarter. Bristol Gate Capital Partners Inc. now owns 514,766 shares of the company’s stock valued at $26,680,000 after buying an additional 15,169 shares in the last quarter. Institutional investors and hedge funds own 67.89% of the company’s stock.

About Dow Chemical

5 Day Chart for NYSE:DOW

To view Vetr’s full report, visit Vetr’s official website.

Receive News & Ratings for Dow Chemical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Co. and related companies with MarketBeat.com's FREE daily email newsletter.